Immuno Biotech organises world's first GcMAF Immunology Conference

The conference will have talks by leading scientists and doctors from around the world and feature new research papers on the uses of GcMAF to restore the body’s immune system to full strength to fight diseases, autism and cancer.

St Peter Port, Guernsey (February 26, 2013) -- The world's first GcMAF conference will be held on the 19th, 20th and 21st of April in the attractive woodland Conference Centre at the Holiday Inn Frankfurt, Germany. Sponsored by Immuno Biotech Ltd, the conference will have talks by leading scientists and doctors from around the world and feature new research papers on the uses of GcMAF to restore the body's immune system to full strength to fight diseases, autism and cancer.

David Noakes, Immuno Biotech's CEO, said, "When research scientists and doctors meet to add together their individual results into one whole, the science takes a great step forward. It's a pooling of the latest discoveries. We expect to come up with a definitive list of synergistic treatments which will allow doctors to treat stage 3 and some stage 4 cancers with the same 80% success that they achieve with GcMAF alone on stage 2 cancers.

"At the moment GcMAF eradicates autism in 15% of cases. By identifying the best complimentary treatments we hope to take that up to 40%. Amongst others, we hope to take ME/CFS from 30 to 50% success. The workshops will encourage informal networking and new ideas. We have a packed programme of talks by leading GcMAF researchers, doctors reporting on their success at eradicating cancer, autism and ME/CFS with GcMAF and, as a result, registrations are already flooding in."

Registration is open now for doctors and research scientists at and, from March 20th, registration opens for members of the public and patients wishing to learn more about GcMAF.

Immuno Biotech extracts and isolates GcMAF molecules from healthy human blood. As part of the process of tests and assays to ensure its GcMAF is active, it has been conducting laboratory research into the methods by which GcMAF destroys cancers cells, and is publishing its first three research papers at international conferences on cancer, immunology and autism. Currently there are over 60 research papers on GcMAF by 142 eminent scientists with new peer-reviewed papers being added at an increasing rate from university teams and doctors from dozens of countries.

The quality of Immuno Biotech's GcMAF has made it the World's leading supplier and the provider of choice for doctors and scientists with the company being cited in eleven research papers to date. Many of the independent research papers on GcMAF are listed on its website

GcMAF is a vital part of the human immune system, which doesn't work without it. However, many diseases including cancer attempt to prevent production of the body's own GcMAF and, if successful, that prevents the immune system from fighting them, resulting in the diseases growing unchecked and becoming chronic.

Immuno Biotech extracts GcMAF molecules from healthy blood. A weekly injection of a tiny clear drop restores the level of GcMAF in the blood to normal, effectively one millionth of a blood transfusion. That enables the body's own immune system to fight the disease, with the only occasional side effects being mild, cold-like symptoms as the immune system starts to function normally. The time it takes for the body to fight the infection and return to being able to produce normal levels of its own GcMAF depends on the severity of the infection or cancer. An eight week course costs €660 including shipping so a typical 24 week course costs under €2000 - a fraction of the cost of conventional treatments. Immuno Biotech has supplied 4,000 patients through 300 doctors in 30 nations.

Immuno Biotech Contact: Beate Keisa, Immuno Biotech Ltd., Ph: 0044 7781 411737, Website: and click "contact" at the top to email.

2012 Statistics Show That Botox Training Will Help Physicians Grow Their Practices

The economy is seeing an upturn and so too is the aesthetic medical industry. The ASPS published that cosmetic procedures, both surgical and minimally invasive were up 5% over 2011. The IAPAM's Aesthetic Medicine Symposium offers the most comprehensive, hands on, live demonstration and didactic instruction in all of the top 5 non-invasive procedures that the ASPS reports on, and offers unparalleled business support to physicians as they build successful aesthetic medical practices and capture the continued growth in the minimally-invasive market in 2013.

Las Vegas, Nevada, USA - February 26, 2013 – Surgical procedures grew only by 1% in 2012, but non-surgical treatments, such as botox, dermal fillers and chemical peels grew by 6%. "More people are turning to the more inexpensive non-invasive procedures rather than surgical cosmetic procedures," says Jeff Russell, Executive Director of the International Association for Physicians in Aesthetic Medicine ( "They may not get the long term benefits of a face lift, but with a combination treatment of botox and dermal fillers, then can get a great result at a fraction of the price." In the recent report from The American Society of Plastic Surgeons (ASPS), there were 13 million non-surgical procedures performed in 2012, and as in 2011, in 2012, the top five minimally-invasive procedures were:

- Botulinum toxin type A (6.1 million procedures, up 8 percent)
- Soft tissue fillers (2 million procedures, up 5 percent)
- Chemical peel (1.1 million procedures, up 2 percent)
- Laser hair removal (1.1 million procedures, up 4 percent)
- Microdermabrasion (974,000 procedures, up 8 percent)

"For the third consecutive year, the overall growth in cosmetic surgery continues to be driven by a significant rise in minimally-invasive procedures," confirmed Dr. Gregory Evans, MD, President of the ASPS.

Jeff Russell concurs. "We are hearing from our members that minimally invasive procedures like botox and other cosmetic injectables, medically supervised hCG weight loss ( as well as laser treatments, microdermabrasion and chemical peels are in tremendous demand by patients, and we are seeing a correlating increase in the demand for our training. Registration for our cornerstone training program, the IAPAM's Aesthetic Medicine Symposium with botox training (, has steadily increased in the last 6 months. Physicians are realizing they not only need to offer botox treatments to their patients, but also laser hair removal, IPL skin rejuvenation, chemical peels, and microdermabrasion. Organizations, like the IAPAM, educate physicians on how to package these treatments for the most appealing and profitable outcomes."

In line with these findings, the IAPAM's Aesthetic Medicine Symposium provides a forum for physicians to immerse themselves in hands-on and live demonstration training on these top 5 minimally invasive procedures. Leading the faculty is a team of renowned, board-certified cosmetic dermatologists who cover aesthetic patient consultations, facial anatomy & musculature, product preparation, pain management, procedural protocols, post treatment issues and continuing practice support. Unlike other programs, the botox training is done in a clean, multi-million dollar medical facility, not a hotel room chair.

For more information on the IAPAM's upcoming Aesthetic Medicine Symposium and/or hCG Physician Training Seminar (, please see or contact the IAPAM at 1-800-219-5108 ext. 704.

Botox is a trademark of Allergan, Inc.

About the International Association for Physicians in Aesthetic Medicine (IAPAM)

The International Association for Physicians in Aesthetic Medicine is a voluntary association of physicians and supporters, which sets standards for the aesthetic medical profession. The goal of the association is to offer education, ethical standards, credentialing, and member benefits. IAPAM membership is open to all licensed medical doctors (MDs), dentists (DDSs/DMDs) doctors of osteopathic medicine (DOs), physicians assistants (PAs) and nurse practitioners (NPs). The IAPAM offers aesthetic medicine and hCG medical weight management programs, including: botox training, medical aesthetic training, laser training, physician hCG training, and aesthetic practice business training. Additional information about the association can be accessed through the IAPAM's website ( or by contacting:

Jeff Russell, Executive-Director
International Association for Physicians in Aesthetic Medicine (IAPAM)
1-800-219-5108 ext. 704